Direct Relief
Pfizer

Diflucan® Partnership Program

Through the Diflucan® Partnership Program, Pfizer's antifungal medicine Diflucan® (fluconazole) is provided free of charge to governments and nongovernmental organizations in developing countries for patients with cryptococcal meningitis and esophageal candidiasis, two opportunistic infections associated with HIV/AIDS.

Diflucan® Partnership Program

Share Map» Contact Us» FAQ»

Focus on South Africa

Distribution by Province: Defined Daily Doses Total:

Photo

Share through Social Media

 Tweet

Share by Email

  Default view of map
  Current customized view

Send Email

Direct Relief

Direct Relief International administers the Diflucan Program in partnership with Pfizer. To learn more about the Diflucan Partnership Program, please visit Direct Relief.

Contact Direct Relief »

Items marked with * are required.

Error

* Your name

* Your email

* Your message

 

Submitting your email...

RESPONSE

Treatment is defined by number of HIV-positive pregnant women and their infants who received single dose nevirapine.

Pfizer Diflucan Partnership Direct Relief

download data

Worldwide Program Results

Diflucan Distribution

Distribution of all formulations of Diflucan measured by Defined Daily Dose (DDD), or the average maintenance dose per day for a drug's main indication in adults.

Timeframe displayed on map:

 to 

Diflucan Formulations

Diflucan Distribution

Select a Diflucan formulation to display on the map:

TB Tablets (28 - 200mg tabs/bottle)

IV IV Solution (200 mg vials)

PS Oral Suspension (bottles)

Timeframe displayed on map:

 to 

Focus on South Africa

2011 Diflucan Distribution

Distribution of all formulations of Diflucan measured by Defined Daily Dose (DDD), or the average maintenance dose per day for a drug's main indication in adults.

Direct Relief International